SCHEMBL858586

SCHEMBL858586

Cc1ncsc1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26118223 0.98
Methylene Chloride SCHEMBL28269018 0.94 ALDH1A1 (0.62)
SCHEMBL259480 0.82
Hydrochloric Acid SCHEMBL14685862 0.80 ALDH1A1 (0.62)
Bromide SCHEMBL3960541 0.80 ALDH1A1 (0.62)
Water SCHEMBL27839644 0.80 ALDH1A1 (0.62)
Bromide SCHEMBL6298964 0.80 ALDH1A1 (0.62)
Bromide SCHEMBL6298962 0.80 ALDH1A1 (0.62)
SCHEMBL290725 0.78
SCHEMBL13066854 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240180891-A1 SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2024-06-06 US claimed
CN-115925649-A Method for preparing 4-methylthiazole-5-formaldehyde by continuous flow 深圳市茵诺圣生物科技有限公司 2023-04-07 CN claimed
WO-2022140279-A1 SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2022-06-30 WO claimed
CN-112778231-A Novel synthesis method of 4-methylthiazole-5-formaldehyde 杭州凯方科技有限公司 2021-05-11 CN claimed
CN-109180704-B Synthesis method of cefditoren pivoxil 齐鲁安替制药有限公司 2020-06-05 CN claimed
CN-109180704-A A kind of synthetic method of Cefditoren pivoxil Cephalosporins 齐鲁安替制药有限公司 2019-01-11 CN claimed
CN-100360511-C Method for synthesizing 4-methyl-5-methyol thiazole UNIV ZHEJIANG TECHNOLOGY (CN) 2008-01-09 CN claimed
CN-1803782-A Method for synthesizing 4-methyl-5-methyol thiazole UNIV ZHEJIANG TECHNOLOGY (CN) 2006-07-19 CN claimed
WO-2005100330-A1 PREPARATION OF INTERMEDIATE FOR 3-[2-(4-METHYLTHIAZOLE-5-YL)VINYL] CEPHALOSPORINS RANBAXY LABORATORIES LIMITED (IN) 2005-10-27 WO claimed
CN-1628108-A Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate ORCHID CHEMICALS & PHARM LTD (IN) 2005-06-15 CN claimed
US-6833459-B2 Reducing thiazole ester to thiazole alcohol using sodium borohydride in the presence of aluminum chloride in a solvent and oxidising the thiazole alcohol to obtain 4-methyl-5-formyl-thiazole ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2004-12-21 US claimed
WO-2003091230-A1 PROCESS FOR THE PREPARATION OF 4-METHYL-THIAZOLE-5-CARBALDEHYDE INTERMEDIATE ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2003-11-06 WO claimed
US-20030204095-A1 Process for the preparation of thiazole intermediate ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2003-10-30 US claimed
US-20260070896-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2026-03-12 US disclosed
WO-2026041663-A1 P2X7 RECEPTOR ANTAGONISTS BREYE THERAPEUTICS APS (DK) 2026-02-26 WO disclosed
US-20250376461-A1 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US disclosed
US-4732977-A BACTERICIDES BRISTOL MYERS COMPANY (US) 1988-03-22 US disclosed
EP-0040696-B1 AMINOTHIADIAZOLES AS GASTRIC SECRETION INHIBITORS MERCK & CO. INC. (US) 1986-08-27 EP disclosed
EP-0040696-A2 Aminothiadiazoles as gastric secretion inhibitors MERCK & CO. INC. (US) 1981-12-02 EP disclosed
US-4200578-A ANTIULCER AGENTS, BLOCKING AGENTS, ANTISECRETORY AGENTS BRISTOL-MYERS COMPANY (US) 1980-04-29 US disclosed